Stockreport

EMA Accepts Rocket (RCKT) Gene Therapy Filing for Fanconi Anemia [Yahoo! Finance]

Rocket Pharmaceuticals, Inc.  (RCKT) 
Last rocket pharmaceuticals, inc. earnings: 3/5 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: rocketpharma.com
PDF FA is a rare genetic disorder that mainly affects the bone marrow. It is also marked by cancer predisposition and congenital malformations. The MAA acceptance is base [Read more]